Indication
Keratoconjunctivitis
2 clinical trials
2 products
Clinical trial
A Multi-Center, Double-Masked, Randomized, Placebo-Controlled, Parallel-Group Study Evaluating the Efficacy, Safety, and Tolerability of Dupilumab in Patients With Atopic Keratoconjunctivitis (AKC)Status: Recruiting, Estimated PCD: 2025-01-01
Product
DupilumabClinical trial
A Phase I Safety and Tolerability Study of PP-001 Eye Drops in Healthy Adult VolunteersStatus: Completed, Estimated PCD: 2021-09-15
Product
PP-001